Physician profile
Jeffrey Pence
NPI 1265963722
$13,326.78
in general payments reported to CMS, 2019-2025
12 companies · $587 in 2025
The $587 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,338 · 2022: $1,536 · 2023: $1,972 · 2024: $1,895 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,423 · Travel and Lodging: $1,945 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,423.32 |
| Travel and Lodging | $1,944.75 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11,329.34 | 2021-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Pacira Pharmaceuticals Incorporated | $1,359.31 | 2022-2024 | Iovera, Exparel, Zilretta |
| Nevro Corp. | $138.21 | 2021 | |
| Zimvie INC. | $120.60 | 2024 | |
| Medtronic, INC. | $88.09 | 2022 | |
| Merz Pharmaceuticals, LLC | $85.00 | 2024 | |
| Spr Therapeutics, INC | $72.62 | 2022-2023 | Sprint Pns System |
| Relievant Medsystems, INC. | $71.42 | 2022-2023 | Intracept |
| Si-Bone, INC. | $26.93 | 2024 | |
| Stryker Corporation | $14.21 | 2021 | |
| Painteq LLC | $13.88 | 2023 | Painteq |
| Vertos Medical, INC. | $7.17 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Pence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.